The polymerase chain reaction (PCR) was used to detect Treponema pallidum DNA in the cerebrospinal fluid (CSF) of patients with and without syphilis. The CSF from 10 of 19 patients with positive serological tests for syphilis who were being investigated for late syphilis were treponemal DNA-positive. In
Introduction
There is clinical evidence that the human immunodeficiency virus (HIV) alters the immune response to Treponema pallidum.'`T. pallidum has been demonstrated in immunocompetent patients after treatment for syphilis,`' but treponemes are more likely to persist in the cerebrospinal fluid (CSF) of patients infected with HIV than in that of patients who are uninfected.'`Furthermore, patients infected with HIV who acquire syphilis may be more likely to progress to clinical neurosyphilis, and at an emes contribute to the neurological disease that is assumed to be caused directly by HIV (subacute encephalopathy) or by other opportunistic infections of the central nervous system (CNS).
We have determined already in the laboratory that the polymerase chain reaction (PCR) is a relatively sensitive and highly specific technique for detecting T. pallidum DNA.`5 In the current study we used the PCR in an attempt to detect treponemal DNA in CSF from patients with and without syphilis, and then to determine the frequency with which treponemal DNA was present in CSF from HIV-infected patients with and without disease of the CNS. A VDRL test proved positive on undiluted CSF which contained 92 white cells/mm3, and 10 g protein/i. The headache resolved following treatment with procaine penicillin which was given at a dose of 1.2 MU daily for 15 days. The other patient had a diagnosis of neurosyphilis established on the basis of a positive VDRL test on CSF. Treponemal DNA was detected by the PCR in the CSF of both of these patients.
Materials and methods
Two patients had a diagnosis of possible asymptomatic neurosyphilis. The TPHA test on the CSF of one of these was strongly positive and treponemal DNA was detected in the CSF. The other patient had an increased concentration of protein in the CSF with a pleocytosis. However, FTA and VDRL tests on the CSF were negative and treponemal DNA was not detected. It subsequently emerged that he had been treated for asymptomatic neurosyphilis at another hospital nine years previously.
Fourteen of the remaining 15 patients had a diagnosis of latent treponemal infection, seven had CSF that reacted positively in the PCR for treponemal DNA. The possibility of yaws existed in only one of these patients and the PCR proved negative.
Two patients were HIV antibody-positive, both with CDC stage 2 disease. One ofthese was patient M with neurosyphilis who was treponemal DNA positive. The other patient had been treated for latent syphilis with erythromycin five years previously and had requested reinvestigation for syphilis. His CSF was normal and treponemal DNA was not detected.
Many of the patients in whose CSF treponemal After treatment with penicillin the VDRL remained unchanged and the patient is being investigated for a paraproteinaemia. It is likely that this was a biological false-positive VDRL. Group C patients Four patients gave a history of syphilis but had Details of these patients and the results of their negative FTA, TPHA and VDRL tests of the serum. investigations are shown in tables 2 and 3. There One of these patients had been treated for primary were 14 patients with CNS disease, of whom seven syphilis with benzathine penicillin 3 years earlier and were treponemal DNA positive. In contrast, of 14 was treponemal DNA positive. Another of the four patients without CNS disease, none were treponemal had been treated abroad and it was not possible to DNA positive (Fishers exact test p < 0 005). confirm the prior diagnosis of syphilis, but he gave a Furthermore, five of eight patients who had a history good description of a chancre and treatment with of syphilis and current CNS disease were treponemal daily injections of penicillin for 15 days. There were DNA positive, while the five patients with a history two men who did not give a history of syphilis and of syphilis but without CNS disease were all trepo-who had negative serological tests for it, in whom nemal DNA negative (Fishers exact test p < 0 05). treponemal DNA was detected. These two men had In group C all the patients were HIV-positive and those known to have syphilis had all been treated. Nevertheless, treponemal DNA was detected in five of 13 patients with a history of syphilis, giving a sensitivity of 38%, a specificity of 87%, a PPV of 87%, and a NPV of 62% for predicting a history of syphilis.
We estimated that DNA equivalent to no less than 65 organisms in 0.5 ml of CSF could be detected by the PCR, which could account for the relatively low sensitivity of the procedure in tests on clinical specimens. However, since this figure was based on multiple dilutions it is possible that the sensitivity is greater than we have estimated. We detected treponemal DNA in the CSF from more than half of the patients with a history of untreated latent syphilis. Previous attempts to detect treponemes in the CSF from patients with late latent syphilis by animal inoculation have failed'0 or have been successful in only a small proportion of patients.'6 Our failure to detect treponemal DNA in specimens from more than 40% of patients with late latent syphilis may be because in a proportion of the patients the infection had been eliminated with or without the assistance of antibiotics prescribed for other conditions. The organisms may not be freely present in CSF, but exist possibly in other tissues or even intracellularly.' Our method does not distinguish between live and dead organisms. It is possible that the differences between our results and those obtained with rabbit inoculation are because the PCR is able to detect non-viable organisms.
The specificity of the PCR was not 100% because CSF from three patients without a history of syphilis reacted positively in the test. Two of these patients were HIV antibody-positive and had negative serological tests for syphilis. It is possible that they had incubating or early syphilis that had been treated fortuitously, resulting in the inability to detect treponemal or reaginic antibody subsequently. Alternatively, they may have failed to produce antibodies as a consequence of their HIV infection.3 Although these two positive results could represent true false positive ones, the overall specificity of the PCR procedure would suggest otherwise. The third patient was in group A and the result must be assumed to be a genuine false positive. Since this work was completed the PCR technique has been modified with the addition of a second amplification cycle for the 4D gene using internal primers ("nested" PCR). Initial results suggest that this provides increased sensitivity and specificity. Although it has not been possible to retest all the samples with this modification, the CSF from the patient in group A that was positive has been retested on three occasions and has been negative each time, while the fluids from the two patients in group C with no prior history of syphilis have been confirmed positive. The initial result for all the other samples that have been retested has been confirmed. While this points to a high specificity of the original tests it also indicates that the probes and primers used initially were not 100% specific and, furthermore, suggests that contamination is not the explanation for these three "false-positives".
In this study CNS disease and a history of syphilis predicted the finding oftreponemal DNA in the CSF ofpatients with HIV infection. Immune 
